Article ; Online: MEK inhibitors as novel host-targeted antivirals with a dual-benefit mode of action against hyperinflammatory respiratory viral diseases.
2023 Volume 59, Page(s) 101304
Abstract: Acute hyperinflammatory virus infections, such as influenza or coronavirus disease-19, are still a major health burden worldwide. In these diseases, a massive overproduction of pro-inflammatory cytokines and chemokines (cytokine storm syndrome) determine ...
Abstract | Acute hyperinflammatory virus infections, such as influenza or coronavirus disease-19, are still a major health burden worldwide. In these diseases, a massive overproduction of pro-inflammatory cytokines and chemokines (cytokine storm syndrome) determine the severity of the disease, especially in late stages. Direct-acting antivirals against these pathogens have to be administered very early after infection to be effective and may induce viral resistance. Here, we summarize data on a host-targeted strategy using inhibitors of the cellular Raf/MEK/ERK kinase cascade that not only block replication of different RNA viruses but also suppress the hyperinflammatory cytokine response upon infection. In the first phase-II clinical trial of that approach, the MEK inhibitor Zapnometinib shows evidence of clinical benefit. |
---|---|
MeSH term(s) | Humans ; Antiviral Agents/therapeutic use ; COVID-19 ; Hepatitis C, Chronic ; Influenza, Human/drug therapy ; Cytokines ; Mitogen-Activated Protein Kinase Kinases/therapeutic use |
Chemical Substances | Antiviral Agents ; Cytokines ; Mitogen-Activated Protein Kinase Kinases (EC 2.7.12.2) |
Language | English |
Publishing date | 2023-02-24 |
Publishing country | Netherlands |
Document type | Journal Article ; Review ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2611378-8 |
ISSN | 1879-6265 ; 1879-6257 |
ISSN (online) | 1879-6265 |
ISSN | 1879-6257 |
DOI | 10.1016/j.coviro.2023.101304 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.